Cochlear Limited (FRA:OC5)

Market Cap	7.80B -36.5%
Revenue (ttm)	1.33B +1.3%
Net Income	196.17M -6.8%
EPS	2.99 -6.6%
Shares Out	n/a
PE Ratio	39.77
Forward PE	29.90
Dividend	2.46 (2.07%)
Ex-Dividend Date	Sep 18, 2025

Volume	n/a
Average Volume	50
Open	119.00
Previous Close	119.64
Day's Range	119.00 - 119.00
52-Week Range	118.46 - 179.94
Beta	n/a
RSI	20.32
Earnings Date	Feb 13, 2026

About Cochlear

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The company was founded in 1981 and is headquartered i...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1981
• Employees: 5,500
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: OC5

Financial Performance

In fiscal year 2025, Cochlear's revenue was 2.34 billion, an increase of 4.81% compared to the previous year's 2.24 billion. Earnings were 388.90 million, an increase of 9.00%.

Financial numbers in AUD